US Stock MarketDetailed Quotes

DWTX Dogwood Therapeutics

Watchlist
  • 2.710
  • +0.280+11.52%
Close Nov 21 15:59 ET
3.61MMarket Cap-428P/E (TTM)

About Dogwood Therapeutics Company

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Company Profile

SymbolDWTX
Company NameDogwood Therapeutics
Listing DateDec 17, 2020
Founded2012
CEOMr. Gregory Duncan
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address44 Milton Avenue
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30009
Phone1-866-620-8655
Websitehttp://www.dwtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Gregory Duncan
  • Chief Executive Officer and Chairman of the Board
  • 936.83K
  • Angela Walsh
  • Chief Financial Officer, Corporate Secretary and Treasurer
  • 426.82K
  • Dr. Roger Michael Gendreau, M.D.,PhD
  • Chief Medical Officer
  • 566.18K
  • Ralph Grosswald
  • Senior Vice President, Operations
  • --
  • Dr. Melvin Toh, PhD
  • Director
  • --
  • Ying Choi Alan Abel Yu
  • Director
  • --
  • Dr. Abel De La Rosa,PhD
  • Independent Director
  • 63.99K
  • Dr. William L. Pridgen, M.D.
  • Independent Director
  • 51.49K
  • Dr. Richard J. Whitley,M.D.
  • Independent Director
  • 64.49K
  • David Keefer
  • Independent Director
  • 72.99K
  • John C. Thomas,Jr
  • Independent Director
  • 66.49K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data